Virtual Presentation

Assessing Antiretroviral Activity: A Practical Guide to Selecting New Agents for Treatment-Experienced Patients

Source: Assessing Antiretroviral Activity: A Practical Guide to Selecting New Agents for Treatment-Experienced Patients

Assessing Antiretroviral Activity: A Practical Guide to Selecting New Agents for Treatment-Experienced Patients


Faculty:

Charles B. Hicks, MD
  • Charles B. Hicks, MD

CME CREDIT INFORMATION

Release Date: 11/21/08

Expiration Date: 11/20/09


Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Status: Please log in to view status

Begin the Virtual Presentation

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the role of resistance testing in assessing the potential activity of an antiretroviral regimen
  • Summarize clinical data pertaining to the impact of NRTI and NNRTI resistance on the efficacy of subsequent lines of therapy with agents from these classes
  • Define what is meant by a high genetic barrier to resistance and cite clinical examples as they relate to PI treatment
  • Discuss the role of agents from new classes in contributing to the number of active agents in an antiretroviral regimen
  • Summarize clinical evidence regarding the ideal number of active agents that should be included in a new antiretroviral regimen for treatment-experienced patients

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.